Home

Omega-3 fatty acids: diagnostic value and role of individual features in patients’ organisms

12 January 2010
Written by Vaskovsky V.E., Gorbach T.A., Esipov A.V., Svetashev V.I., Yatskova M.A.

  UDK: 616‑074:577.115.3 | Pages: 23–25 | Read full textDownload PDF 

Annotation:

The authors have created an express method for detecting fatty acid composition in whole blood intended to diagnose the state of patients by the level of omega 3 fatty acids in their organisms and monitor the effects from these acids when taking drugs. This method allowed testing blood taken from about 180 patients. The findings have varied in a wide range. The authors began working to identify factors appeared to have effect on the fatty acid composition in blood. In case of volunteers, it is evident that the linseed oil cannot be considered as active omega 3 fatty acid drug. As reported, the acid‑containing drugs should be used as part of the personalised medicine.

Links to authors:

V.E. Vaskovsky, V.I. Svetashev, M.A. Yatskova
Institute of Marine Biology (17 Palchevskogo St. Vladivostok 690041 Russia),
V.E. Vaskovsky, A.V. Esipov
Pacific Institute of Bioorganic Chemistry of the Far Eastern Branch of Russian Academy of Sciences (159 100 Year Anniversary of Vladivostok Av. Vladivostok 690022 Russia),
T.A. Gorbach
Medical Association of FEB RAS (95 Kirova St. Vladivostok 690022 Russia)

  1. Vaskovskij V.E., Gorbach T.A., Esipov A.V. et.al. Preparations of
    the omega‑3 fatty acids and their use in medicine, Pacific Medical
    Journal. 2010. No. 2. P. 16–20.
    2. Albert C.M., Campos H., Stampfer M.J. et al. Blood levels of long‑
    chain n‑3 fatty acids and the risk of sudden death, New Engl. J.
    Med. 2002. Vol. 346, No. 15. P. 1113–1118.
    3. Beydoun M.A., Kaufman J.S., Satia J.A. et al. Plasma n‑3 fatty
    acids and the risk of cognitive decline in older adults: the ath‑
    erosclerosis risk in communities study, Am. J. Clin. Nutrit. 2007.
    Vol. 85, No. 4. P. 1103–1111.
    4. Bicalho B., David F., Rumplel K. et al.Creating a fatty acid methyl
    ester database for lipid profiling in a single drop of human
    blood using high resolution capillary gas chromatography and
    mass spectrometry, J. Chromatogr. A. 2008. Vol. 1211, No. 1–2.
    P. 120–128.
    5. Burdge G. α‑Linolenic acid metabolism in men and women:
    nutritional and biological implications, Current Opinion Clinical
    Nutrit. Metabol. Care. 2004. Vol. 7, No. 2. P. 137–144.
    6. Di Minno M.N.D., Tremoli E., Tufano A. et al. Exploring newer
    cardioprotective strategies: omega‑3 fatty acids in perspective,
    Thromb. Haemostasis. 2010. Vol. 104, No. 4. P. 664–680.
    7. Huang T.L. Omega‑3 fatty acids, cognitive decline, and Alzheim‑
    er’s disease: A critical review and evaluation of the literature, J.
    Alzheimers Disease. 2010. Vol. 21, No. 3. P. 673–690.
    8. Kirby A., Woodward A., Jackson S. Benefits of omega‑3 supple‑
    mentation for schoolchildren: review of the current evidence, Brit.
    Educat. Res. J. 2010. Vol. 36, No. 5. P. 699–732.
    9. Kuriki K., Hirose K., Wakai K. et al. Breast cancer risk and
    erythrocyte compositions of n‑3 highly unsaturated fatty acids in
    Japanese, Int. J. Cancer. 2007. Vol. 121, No. 2. P. 377–385.
    10. Nogi A., Yang J.J., Li L.M. et al. Plasma n‑3 polyunsaturated fatty
    acid and cardiovascular disease risk factors in Japanese, Korean
    and Mongolian workers, J. Occupat. Health. 2007. Vol. 49, No. 3.
    P. 205–216.
    11. Rizzo A.M., Montorfano G., Negroni M. et al. A rapid method for
    determining arachidonic: eicosapentaenoic acid ratios in whole
    blood lipids: correlation with erythrocyte membrane ratios and
    validation in a large Italian population of various ages and pa‑
    thologies, Lipids in Health and Disease. 2010. Vol. 9. Art. No. 7.
    12. Simopoulos A.P. Genetic variants in the metabolism of omega‑6
    and omega‑3 fatty acids: their role in the determination of nu‑
    tritional requirements and chronic disease risk, Exp. Biol. Med.
    2010. Vol. 235, No. 7. P. 785–795.
    13. Stransky K., Jursik T., Vitek A. Standard equivalent chain length
    values of monoenic and polyenic (methylene–interrupted) fatty
    acids, J. High Resol. Chromatogr. 1997. Vol. 20, No. 3. P. 143–158.
    14. Turner D., Shah P.S., Steinhart A.H. et al. Maintenance of remis‑
    sion in inflammatory bowel disease using omega‑3 fatty acids
    (fish oil): A systematic review and meta‑analyses, Inflamm. Bowel
    Diseases. 2011. Vol. 17, No. 1. P. 336–345.
    15. Virtanen J.K., Mursu J., Voutilainen S., Tuomainen T.P. Serum
    long‑chain n‑3 polyunsaturated fatty fcids and risk of hospital
    diagnosis of atrial fibrillation in men, Circulation. 2009. Vol. 120,
    No. 23. P. 2315–2321.

PUBLISHER: "MEDITSYNA DV"

Founded in 1997  |  Editions in a year: 4, Articles in one issue: 30 |  ISSN of print version: 1609-1175  |  Ind.: 18410 (Agency "Rospechat’")  |  Edition: 1000 c.